Our data suggest that similar to the tumor agnostic activity of checkpoint blockade, MMR deficiency and MSI-H status represent a genetic determinant for WRN dependency regardless of tumor type. This evidence concerns the gene MRC1 and hyperinsulinemic hypoglycemia, familial, 4.